Oral antidiabetic treatment in patients with coronary disease: Time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up-Reference-Cited by-同舟云学术

Oral antidiabetic treatment in patients with coronary disease: Time-related increased mortality on combined glyburide/metformin therapy over a 7.7-year follow-up

Published:2001-02 Issue:2 Volume:24 Page:151-158
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Fisman Enriqe Z.,Tenenbaum Alexander,Adler Yehuda,Motro Michael,Boyko Valentina,Benderly Michal,Friedensohn Aharon,Kohanovski Mira,Rotzak Rene,Schneider Hanan,Behar Solomon

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/clc.4960240210/fullpdf

Reference41 articles.

1. Reappraisal of the role of the diabetic state in coronary artery disease;Hamby;Chest,1976

2. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus;The DCCT Trials;N Engl J Med,1993

3. the Scandinavian Simvastatin Survival Study (4S) Group: Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S);Pyorala;Diabetes Care,1997

4. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38);UK Prospective Diabetes Study Group;Br Med J,1998

5. Hypertension in diet versus pharmacologically treated diabetics. Mortalits over a 5-year follow-up;Tenenbaum;Hypertension,1999

Cited by 98 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of nanosystems in the delivery of glucose-lowering drugs for the preemption and treatment of diabetes-associated atherosclerosis;American Journal of Physiology-Cell Physiology;2024-05-01

2. Association of Metformin with the Mortality and Incidence of Cardiovascular Events in Patients with Pre-existing Cardiovascular Diseases;Drugs;2022-01-15

3. Sulfonylureas in the Current Practice of Type 2 Diabetes Management: Are They All the Same? Consensus from the Gulf Cooperation Council (GCC) Countries Advisory Board on Sulfonylureas;Diabetes Therapy;2021-05-13

4. Cardiovascular events and mortality among type 2 diabetes mellitus patients newly prescribed first-line blood glucose-lowering drugs monotherapies: A population-based cohort study in the Catalan electronic medical record database, SIDIAP, 2010-2015;Primary Care Diabetes;2021-04

5. New antihyperglycaemic agents and cardiovascular disease;Current Opinion in Cardiology;2018-07